Revelation Biosciences Stock Probability of Future Stock Price Finishing Over 9.72
| REVBW Stock | USD 0.01 0 16.50% |
Revelation |
Revelation Biosciences Target Price Odds to finish over 9.72
The tendency of Revelation Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 9.72 or more in 90 days |
| 0.01 | 90 days | 9.72 | close to zero percent |
Based on a normal probability distribution, the odds of Revelation Biosciences to move over $ 9.72 or more in 90 days from now is close to zero percent (This Revelation Biosciences probability density function shows the probability of Revelation Stock to fall within a particular range of prices over 90 days) . Probability of Revelation Biosciences price to stay between its current price of $ 0.01 and $ 9.72 at the end of the 90-day period is about 68.04 .
Assuming the 90 days horizon Revelation Biosciences has a beta of -1.57 indicating as returns on its benchmark rise, returns on holding Revelation Biosciences are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Revelation Biosciences is expected to outperform its benchmark. Moreover Revelation Biosciences has an alpha of 1.1992, implying that it can generate a 1.2 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Revelation Biosciences Price Density |
| Price |
Predictive Modules for Revelation Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Revelation Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Revelation Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Revelation Biosciences is not an exception. The market had few large corrections towards the Revelation Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Revelation Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Revelation Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.20 | |
β | Beta against Dow Jones | -1.57 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.06 |
Revelation Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Revelation Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Revelation Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Revelation Biosciences generated a negative expected return over the last 90 days | |
| Revelation Biosciences has high historical volatility and very poor performance | |
| Revelation Biosciences has some characteristics of a very speculative penny stock | |
| Revelation Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (120.25 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revelation Biosciences has accumulated about 4.14 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.79, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Revelation Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Revelation Bio Achieves Key Manufacturing Milestone for Kidney Disease Drug Trial REVB Stock News - StockTitan |
Revelation Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Revelation Stock often depends not only on the future outlook of the current and potential Revelation Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Revelation Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 228.6 K | |
| Cash And Short Term Investments | 12 M |
Revelation Biosciences Technical Analysis
Revelation Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Revelation Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Revelation Biosciences. In general, you should focus on analyzing Revelation Stock price patterns and their correlations with different microeconomic environments and drivers.
Revelation Biosciences Predictive Forecast Models
Revelation Biosciences' time-series forecasting models is one of many Revelation Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Revelation Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Revelation Biosciences
Checking the ongoing alerts about Revelation Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Revelation Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Revelation Biosciences generated a negative expected return over the last 90 days | |
| Revelation Biosciences has high historical volatility and very poor performance | |
| Revelation Biosciences has some characteristics of a very speculative penny stock | |
| Revelation Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (120.25 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Revelation Biosciences has accumulated about 4.14 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.79, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Revelation Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Revelation Bio Achieves Key Manufacturing Milestone for Kidney Disease Drug Trial REVB Stock News - StockTitan |
Additional Tools for Revelation Stock Analysis
When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.